<PAGE>






                 SECURITIES AND EXCHANGE COMMISSION

                       Washington, D.C. 20549

                              FORM 8-K

                           CURRENT REPORT


  Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

  Date of Report (Date of earliest event reported) January 5, 2000

                         Jayark Corporation

       (Exact name of registrant as specified in its charter)

Delaware                 0-3255                        13-1864519
(State of incorporation) (Commission File#)            (IRS EIN)




         Post Office Box 741528, Houston, Texas       77274
       (Address of principal executive offices)     (Zip Code)


  Registrant's telephone number, including are code:  713-783-9184


                                 N/A

   (Former name or former address, if changed since last report.)


<PAGE>

Item 5.   Other Events


On  January  5,  2000 Jayark Corporation (the "Company"),  through  a
newly  formed,  wholly owned subsidiary, Fisher  Medical  Corporation
("Fisher"),  entered  into an Asset Purchase  Agreement  with  Fisher
Medical,  LLC, a company that develops, manufactures and  distributes
medical  supplies  and  equipment for hospitals,  nursing  homes  and
individuals.  Under the terms of the agreement, Fisher purchased  all
of  the  assets of Fisher Medical, LLC for cash of $215,000.   Fisher
then  entered  into Employment Agreements with the two principals  of
Fisher  Medical,  LLC  to  continue  developing,  manufacturing   and
distributing  medical products of Fisher.  In consideration  for  the
Employment  Agreements,  the two principals also  entered  into  Non-
Disclosure  and  Non-Competition  Agreements.  Fisher  financed  this
purchase  from  the Company's existing $1,250,000 revolving  line  of
credit.

If  Fisher  can develop, manufacture and distribute medical  supplies
and  equipment, the income and cash flow could have a material affect
on  the  operating results of Jayark Corporation.  There  can  be  no
assurances that the Company will be successful in this venture.


<PAGE>

                             SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.


JAYARK CORPORATION

Registrant

By:  /s/ David L. Koffman                         Dated: January 5, 2000
     President, Chief Executive Officer


<PAGE>
[{"type": "8-K", "sequence": "1", "description": "8-K REPORT DATED JANUARY 5, 2000", "secsgml_size_bytes": 2504}]
{"company-data": {"conformed-name": "JAYARK CORP", "cik": "0000053260", "assigned-sic": "5020", "irs-number": "131863419", "state-of-incorporation": "DE", "fiscal-year-end": "0430"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-03255", "film-number": "504478"}, "business-address": {"street1": "PO BOX 741528", "city": "HOUSTON", "state": "TX", "zip": "77274", "phone": "7137839184"}, "mail-address": {"street1": "P O BOX 741528", "city": "HOUSTON", "state": "TX", "zip": "77274"}, "former-company": {"former-conformed-name": "JAYARK FILMS CORP", "date-changed": "19700903"}}
SECURITIES AND EXCHANGE COMMISSION

                       Washington, D.C. 20549

                              FORM 8-K

                           CURRENT REPORT

  Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

  Date of Report (Date of earliest event reported) January 5, 2000

                         Jayark Corporation

       (Exact name of registrant as specified in its charter)

Delaware                 0-3255                        13-1864519
(State of incorporation) (Commission File#)            (IRS EIN)

         Post Office Box 741528, Houston, Texas       77274
       (Address of principal executive offices)     (Zip Code)

  Registrant's telephone number, including are code:  713-783-9184

                                 N/A

   (Former name or former address, if changed since last report.)
Item 5.   Other Events

On  January  5,  2000 Jayark Corporation (the "Company"),  through  a
newly  formed,  wholly owned subsidiary, Fisher  Medical  Corporation
("Fisher"),  entered  into an Asset Purchase  Agreement  with  Fisher
Medical,  LLC, a company that develops, manufactures and  distributes
medical  supplies  and  equipment for hospitals,  nursing  homes  and
individuals.  Under the terms of the agreement, Fisher purchased  all
of  the  assets of Fisher Medical, LLC for cash of $215,000.   Fisher
then  entered  into Employment Agreements with the two principals  of
Fisher  Medical,  LLC  to  continue  developing,  manufacturing   and
distributing  medical products of Fisher.  In consideration  for  the
Employment  Agreements,  the two principals also  entered  into  Non-
Disclosure  and  Non-Competition  Agreements.  Fisher  financed  this
purchase  from  the Company's existing $1,250,000 revolving  line  of
credit.

If  Fisher  can develop, manufacture and distribute medical  supplies
and  equipment, the income and cash flow could have a material affect
on  the  operating results of Jayark Corporation.  There  can  be  no
assurances that the Company will be successful in this venture.
SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.

JAYARK CORPORATION

Registrant

By:  /s/ David L. Koffman                         Dated: January 5, 2000
     President, Chief Executive Officer